Baldrige Asset Management’s AbbVie ABBV Stock Holding History

Baldrige Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$58K	Buy	364 +10	+3%	+$1.53K	0.02%	168
2022 Q4	$57K	Buy	354 +258	+269%	+$39.6K	0.03%	171
2022 Q3	$13K	Hold	96	–	–	0.01%	232
2022 Q2	$15K	Hold	96	–	–	0.01%	231
2022 Q1	$16K	Hold	96	–	–	0.01%	240
2021 Q4	$13K	Hold	96	–	–	0.01%	259
2021 Q3	$10K	Hold	96	–	–	﹤0.01%	277
2021 Q2	$11K	Buy	+96	New	+$10.8K	﹤0.01%	278

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Baldrige Asset Management's ABBV Position: Q1 2023 in Review

Baldrige Asset Management increased its AbbVie (ABBV) stake by 2.8% in Q1 2023, buying an estimated $1.53K and bringing the position to 364 shares worth $58K. The position accounts for 0.02% of the portfolio, ranked #168.

Baldrige Asset Management first reported a position in ABBV in Q2 2021 and has held it in 8 quarters since. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Baldrige Asset Management held 364 shares of AbbVie worth $58K as of Q1 2023.
Baldrige Asset Management bought 10 AbbVie shares in Q1 2023, an estimated $1.53K.
AbbVie made up 0.02% of Baldrige Asset Management's portfolio in Q1 2023, its #168 holding.
Baldrige Asset Management first reported a position in AbbVie in Q2 2021 and has held it in 8 quarters since.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.